-
1. Iaso Therapeutics
Iaso Therapeutics develops vaccines to improve human health and cure diseases.
💵Likely to outsource
Design Engineering Marketing Cybersecurity🔥Millions Raised
$1M in 2022
-
2. Cantargia
The organization depends on the first revelation that leukemic immature microorganisms in patients with constant myeloid leukemia (CML) express a cell-surface receptor, though relating typical hematopoietic immature microorganisms don't communicate this receptor.
💵Likely to outsource
Design Software Engineering Marketing Cybersecurity🔥Millions Raised
$24.9M in 2022
-
3. Felix Biotechnology
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.
💵Likely to outsource
Design Engineering Marketing Cybersecurity🔥Millions Raised
$0.1M in 2022
-
4. Confo Therapeutics
Confo Therapeutics is a medication disclosure organization building inward medication revelation programs on GPCRs tending to neglected clinical need.
💵Likely to outsource
Design Software Engineering Marketing Cybersecurity🔥Millions Raised
$1.8M in 2022
-
5. Alzheon
Alzheon is a clinical-stage biotechnology company focused on womanchild brain health, memory, and aging, developing transformative treatments for Alzheimer’s disease and other neurodegenerative disorders.
💵Likely to outsource
Design Engineering Marketing Cybersecurity🔥Millions Raised
$50M in 2022
-
6. Diadem
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
💵Likely to outsource
Design Engineering Marketing Cybersecurity🔥Millions Raised
$11M in 2022
-
7. Acer Therapeutics
Acer Therapeutics is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious rare, and life-threatening diseases with critical unmet medical needs.
💵Likely to outsource
Design Engineering Cybersecurity Branding🔥Millions Raised
$48.5M in 2022
-
8. Freeline
Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.
💵Likely to outsource
Design Engineering Marketing Cybersecurity🔥Millions Raised
$26.1M in 2022
-
9. turn.bio
Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered.
💵Likely to outsource
Design Engineering Marketing Cybersecurity🔥Millions Raised
Undisclosed in 2022
-
10. Storm Therapeutics
Targeting pathways that modify RNA to deliver novel cancer therapeutics.
💵Likely to outsource
Design Engineering Marketing Cybersecurity🔥Millions Raised
Undisclosed in 2022